Home › Funds › Venrock Adviser, LLC › IPSC
Venrock Adviser, LLC position in IPSC
CENTURY THERAPEUTICS INC · Health Care
Venrock Adviser, LLC reported holding 8,695,652 shares of IPSC (CENTURY THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$21.3M, representing 0.65% of its reported portfolio and ranking #23 among its reported holdings. Venrock Adviser, LLC has disclosed IPSC holdings in 7 of the last 10 reported quarters, going back to Q1 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Venrock Adviser, LLC's IPSC position evolved
Venrock Adviser, LLC first disclosed a stake in IPSC in Q1 2024 at 3,405,133 shares (US$14.2M). The position peaked in Q2 2026 at 8,695,652 shares, worth US$21.3M. Across 7 filings, Venrock Adviser, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 8,695,652 shares valued at US$21.3M. Notable position changes include a 58% increase in Q2 2024 (shares fell 33% over the following quarter), a 27% trim in Q4 2024 (shares fell 53% over the following quarter), a 37% trim in Q1 2025 (shares rose 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 3.41M | $14.23M | New |
| Q2 2024 | 5.39M | $13.74M | Add |
| Q3 2024 | 5.39M | $9.22M | Hold |
| Q4 2024 | 3.96M | $4.00M | Reduce |
| Q1 2025 | 2.50M | $1.19M | Reduce |
| Q1 2026 | 8.70M | $19.65M | New |
| Q2 2026 | 8.70M | $21.30M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IPSC and 13F data
IPSC (CENTURY THERAPEUTICS INC) is a Health Care company. 53 other funds we track also report a position in IPSC — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$43.5M), TCG Crossover Management, LLC (US$43.4M), Versant Venture Management, LLC (US$29.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IPSC
- RA CAPITAL MANAGEMENT, L.P. 17.75M sh · $43.50M · Q2 2026
- TCG Crossover Management, LLC 17.75M sh · $43.40M · Q2 2026
- Versant Venture Management, LLC 12.17M sh · $29.81M · Q2 2026
- Commodore Capital LP 8.70M sh · $21.30M · Q2 2026
- Seven Fleet Capital Management LP 4.35M sh · $10.65M · Q2 2026
- Trails Edge Capital Partners, LP 4.13M sh · $10.13M · Q2 2026
- Spruce Street Capital LP 4.06M sh · $9.94M · Q2 2026
- DAFNA Capital Management LLC 2.40M sh · $5.88M · Q2 2026
- STEMPOINT CAPITAL LP 2.15M sh · $5.26M · Q2 2026
- DV Trading LLC 1.40M sh · $3.43M · Q2 2026
- Casdin Capital 1.23M sh · $3.01M · Q2 2026
More on Venrock Adviser, LLC
FAQ
How long has Venrock Adviser, LLC held IPSC?
Venrock Adviser, LLC has disclosed IPSC holdings in 7 of the last 10 reported quarters, going back to Q1 2024.
What is Venrock Adviser, LLC's current position in IPSC?
As of Q2 2026, Venrock Adviser, LLC holds 8.70M shares of IPSC (CENTURY THERAPEUTICS INC), valued at $21.30M, representing 0.65% of its reported portfolio and ranking #23.
Has Venrock Adviser, LLC been buying or selling IPSC?
In the latest 13F filing (Q2 2026), Venrock Adviser, LLC held unchanged its position in IPSC. The position peaked in Q2 2026 at 8.70M shares.
Which other funds hold IPSC?
Other major institutional holders of IPSC include RA CAPITAL MANAGEMENT, L.P., TCG Crossover Management, LLC, Versant Venture Management, LLC, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.